Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine
SH2023-9
Approved mab active
Quick answer
Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine for SARS-CoV-2 Infection is a Approved program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- SARS-CoV-2 Infection
- Phase
- Approved
- Modality
- mab
- Status
- active